News

Filter

Current filters:

Ranbaxy LaboratoriesLegal

26 to 35 of 96949 results

Novartis' Signifor approved in EU for acromegaly patients

Novartis' Signifor approved in EU for acromegaly patients

25-11-2014

The European Commission has approved Swiss drug major Novartis’ Signifor (pasireotide) for patients…

NovartisPharmaceuticalRare diseasesRegulationSigniforSwitzerland

AstraZeneca’s Duaklir Genuair approved in the EU for COPD

AstraZeneca’s Duaklir Genuair approved in the EU for COPD

25-11-2014

The European Commission has granted marketing authorization for Anglo-Swedish pharma major AstraZeneca’s…

AstraZenecaDuaklir GenuairPharmaceuticalRegulationRespiratory and PulmonaryUK

US FDA pushes back decision date for Novartis’ panobinostat

US FDA pushes back decision date for Novartis’ panobinostat

25-11-2014

The US Food and Drug Administration has extended its priority review period by up to three months for…

FarydakNovartisOncologypanobinostatPharmaceuticalRegulationUSA

BioMarin to acquire Prosensa for up to $840 million

BioMarin to acquire Prosensa for up to $840 million

24-11-2014

US drugmaker BioMarin Pharmaceutical has entered into a definitive agreement to purchase all of the outstanding…

BioMarin PharmaceuticaldrisapersenMergers & AcquisitionsPharmaceuticalProsensaRare diseases

GPhA slams mischaracterized facts about generic drug pricing

GPhA slams mischaracterized facts about generic drug pricing

24-11-2014

Commenting on recent evaluations of generic drug prices, Ralph Neas, president and chief executive of…

GenericsLegalPoliticsPricingUSA

Merck gains rights to NewLink Genetics investigational Ebola vaccine

24-11-2014

US pharma giant Merck & Co has entered into an exclusive worldwide license agreement to research, develop,…

Anti-viralsBiotechnologyGlobalLicensingMerck & CoNewLink GeneticsResearchrVSV-EBOYTropical diseases

Amgen halts all its trials of rilotumumab in advanced gastric cancer

24-11-2014

USA-based Amgen has terminated all company-sponsored clinical studies of rilotumumab in advanced gastric…

AmgenBiotechnologyOncologyResearchrilotumumab

Bristol-Myers Squibb partners with Five Prime on immunotherapy combination trials

Bristol-Myers Squibb partners with Five Prime on immunotherapy combination trials

24-11-2014

US drug major Bristol-Myers Squibb and protein therapeutics specialist Five Prime Therapeutics are to…

BiotechnologyBristol-Myers SquibbFive Prime TherapeuticsOncologyOpdivoResearchUSA

Trimel and Endo agree on Natesto manufacturing and marketing collaboration

Trimel and Endo agree on Natesto manufacturing and marketing collaboration

24-11-2014

Trimel Biopharma, a subsidiary of Canada's Trimel Pharmaceuticals Corp, has signed an agreement with…

CanadaEndoLicensingMarkets & MarketingMen's HealthPharmaceuticalTrimel PharmaceuticalsUSA

26 to 35 of 96949 results

Parexel

Parexel

Back to top